A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine.
暂无分享,去创建一个
R. Schilsky | M. Ratain | N. Vogelzang | H. Kindler | S. Olson | L. Janisch | S. Undevia | K. A. Kimmel | T. Macek | Stephen C. Olson | Thomas A. Macek